Published on 21 Jan 2024 on GuruFocus.com via Yahoo Finance
IDEAYA Biosciences Inc President and CEO Yujiro Hata Sells 75,000 Shares
On January 16, 2024, President and CEO Yujiro Hata sold 75,000 shares of IDEAYA Biosciences Inc (NASDAQ:IDYA), as reported in a recent SEC filing. The insider executed the sale at an average price of $40.15 per share, resulting in a total transaction amount of $3,011,250.
IDEAYA Biosciences Inc is a precision medicine company focused on the discovery and development of targeted therapeutics for patients with cancer. The company is dedicated to improving the treatment of cancer through personalized medicine, leveraging its expertise in molecular diagnostics and bioinformatics to identify and develop targeted therapies.
Warning! GuruFocus has detected 5 Warning Signs with IDYA.